CD8A and neoplasm: It was recently demonstrated that certain anti-PD-L1 blocking antibodies are capable of inducing apoptosis of effector PD-L1+ CD8+ T cells through activating the p38 MAPK pathway, and are thus ineffective as tumor treatments (42).